Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 6:21 AM ET


Company Overview of Hemobiotech, Inc.

Executive Profile

Arthur P. Bollon Ph.D.

Consultant and Independent Director, Hemobiotech, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 5 different industries.

See Board Relationships


Dr. Arthur P. Bollon, Ph.D serves as a Consultant to a number of major companies, including Merck, Sharp & Dohme, and Diamond Shamrock. Dr. Bollon served as the Chief Executive Officer and President of Hemobiotech Inc. from April 8, 2003 to August 2010. He founded eXegenics Inc. and served as its Executive Vice President and as a member of the team comprising the Office of the Chief Scientific Officer. In 2003, Dr. Bollon Co-founded Biogress LLC and Quantum Biotech Inc. ...

Corporate Headquarters

5001 Spring Valley Road
Dallas, Texas 75244

United States

Phone: 972-455-8950
Fax: 972-455-8951

Board Members Memberships

Member Of the Scientific Advisory Board and Independent Director
Consultant and Independent Director


Yale University
Rutgers, The State University of New Jersey

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Hemobiotech, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at